1. Home
  2. BLFY vs BWAY Comparison

BLFY vs BWAY Comparison

Compare BLFY & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFY
  • BWAY
  • Stock Information
  • Founded
  • BLFY 1939
  • BWAY 2003
  • Country
  • BLFY United States
  • BWAY Israel
  • Employees
  • BLFY N/A
  • BWAY N/A
  • Industry
  • BLFY Commercial Banks
  • BWAY Medical/Dental Instruments
  • Sector
  • BLFY Finance
  • BWAY Health Care
  • Exchange
  • BLFY Nasdaq
  • BWAY Nasdaq
  • Market Cap
  • BLFY 213.4M
  • BWAY 177.4M
  • IPO Year
  • BLFY N/A
  • BWAY 2019
  • Fundamental
  • Price
  • BLFY $9.41
  • BWAY $10.23
  • Analyst Decision
  • BLFY Hold
  • BWAY Strong Buy
  • Analyst Count
  • BLFY 2
  • BWAY 3
  • Target Price
  • BLFY $11.50
  • BWAY $13.17
  • AVG Volume (30 Days)
  • BLFY 58.2K
  • BWAY 50.2K
  • Earning Date
  • BLFY 01-29-2025
  • BWAY 03-05-2025
  • Dividend Yield
  • BLFY N/A
  • BWAY N/A
  • EPS Growth
  • BLFY N/A
  • BWAY N/A
  • EPS
  • BLFY N/A
  • BWAY 0.04
  • Revenue
  • BLFY $40,112,000.00
  • BWAY $38,631,000.00
  • Revenue This Year
  • BLFY N/A
  • BWAY $388.82
  • Revenue Next Year
  • BLFY $16.19
  • BWAY $18.70
  • P/E Ratio
  • BLFY N/A
  • BWAY $129.57
  • Revenue Growth
  • BLFY N/A
  • BWAY 34.19
  • 52 Week Low
  • BLFY $7.90
  • BWAY $4.61
  • 52 Week High
  • BLFY $11.48
  • BWAY $10.98
  • Technical
  • Relative Strength Index (RSI)
  • BLFY 41.07
  • BWAY 61.17
  • Support Level
  • BLFY $9.18
  • BWAY $9.18
  • Resistance Level
  • BLFY $9.52
  • BWAY $9.75
  • Average True Range (ATR)
  • BLFY 0.29
  • BWAY 0.34
  • MACD
  • BLFY 0.03
  • BWAY 0.11
  • Stochastic Oscillator
  • BLFY 54.92
  • BWAY 88.67

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: